Holen Sie sich die Stockscreener-App
2.265
5.07%
0.095
Maxcyte Inc Aktie (MXCT) Neueste Nachrichten
MaxCyte Shareholders Approve Equity Plan Amendment - TipRanks
MaxCyte shareholders approve equity plan expansion, AIM delisting - Investing.com
Analyzing Ratios: MaxCyte Inc (MXCT)’s Financial Story Unveiled - DWinneX
California State Teachers Retirement System Sells 82,134 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte Announces Change in Major Holdings by BlackRock - TipRanks
MaxCyte and Ori Biotech partner to enhance cell therapy manufacturing By Investing.com - Investing.com South Africa
MaxCyte & Ori Biotech Integrate Platforms for Efficient Manufacturing - Contract Pharma
Market news - investments.halifax.co.uk
MaxCyte enters collaboration with Ori Biotech - Sharecast.com
MaxCyte (MXCT) Partners with Ori Biotech to Boost Cell Therapy Manufacturing | MXCT Stock News - GuruFocus
MaxCyte and Ori Biotech partner to enhance cell therapy manufacturing - Investing.com Australia
MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies - The Manila Times
MaxCyte and Ori Biotech Forge Strategic Partnership to Enhance Cell Therapy Manufacturing Efficiency - Nasdaq
MaxCyte and Ori Biotech Join Forces to Transform CAR-T Cell Production Timeline and Efficiency - Stock Titan
MaxCyte and Ori Biotech Collaborate to Enhance Cell Therapy Manufacturing - TipRanks
Kalkine: NASDAQ Today Sees Movement in MaxCyte Amid Sector-Wide Shifts - Kalkine Media
Squarepoint Ops LLC Decreases Position in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
Two Sigma Advisers LP Purchases Shares of 17,800 MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte (NASDAQ:MXCT) Rating Increased to Hold at Wall Street Zen - Defense World
MaxCyte Announces Change in Voting Rights Structure - TipRanks
BlackRock Increases Stake in MaxCyte to 9.98% - TipRanks
Nuveen Asset Management LLC Cuts Stake in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
ProShare Advisors LLC Has $143,000 Stake in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
BNP Paribas Financial Markets Takes $56,000 Position in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
BlackRock Increases Stake in MaxCyte - TipRanks
MaxCyte Expands Stock Capital Amidst Strategic Growth - TipRanks
Jane Street Group LLC Purchases 12,209 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte (NASDAQ:MXCT) Downgraded to “Sell” Rating by Wall Street Zen - Defense World
Deutsche Bank AG Buys 38,782 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
D. E. Shaw & Co. Inc. Buys 84,105 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte Announces Change in Major Shareholder Voting Rights - TipRanks
BlackRock Increases Stake in MaxCyte, Boosting Voting Rights - TipRanks
BlackRock Increases Stake in MaxCyte to 7.65% - TipRanks
Price T Rowe Associates Inc. MD Has $177,000 Position in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte Announces Change in Major Shareholder Holdings - TipRanks
MaxCyte, Inc. (MXCT): A Bull Case Theory - MSN
MaxCyte Inc (MXCT): Be Patient, You Will Learn - Stocksregister
MaxCyte, Inc. (NASDAQ:MXCT) Q1 2025 Earnings Call Transcript - Insider Monkey
MaxCyte’s Earnings Call: Navigating Challenges and Opportunities - TipRanks
William Blair Predicts MaxCyte’s Q2 Earnings (NASDAQ:MXCT) - Defense World
Hsbc Holdings PLC Purchases 16,554 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte Files Form 10-Q for Q1 2025 - TipRanks
BTIG cuts MaxCyte stock price target to $5, maintains Buy rating - Investing.com
MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates - MSN
MaxCyte (MXCT) Upgraded to Buy: Here's What You Should Know - MSN
Earnings call transcript: MaxCyte Q1 2025 beats revenue forecast, stock reacts - Investing.com
Wells Fargo & Company MN Boosts Holdings in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance - The Manila Times
MaxCyte Inc reports results for the quarter ended March 31Earnings Summary - TradingView
0.25%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):